Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin

Jeremy R. Graff, Stephen G. Zimmer, Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clinical & Experimental Metastasis. ,vol. 20, pp. 265- 273 ,(2003) , 10.1023/A:1022943419011

Gideon Koren, Sandra Knowles, Elizabeth Phillips, Susan King, Ribavirin in the treatment of SARS: A new trick for an old drug? Canadian Medical Association Journal. ,vol. 168, pp. 1289- 1292 ,(2003)

Jeremy R. Graff, Bruce W. Konicek, Thomas M. Vincent, Rebecca L. Lynch, David Monteith, Spring N. Weir, Phil Schwier, Andrew Capen, Robin L. Goode, Michele S. Dowless, Yuefeng Chen, Hong Zhang, Sean Sissons, Karen Cox, Ann M. McNulty, Stephen H. Parsons, Tao Wang, Lillian Sams, Sandaruwan Geeganage, Larry E. Douglass, Blake Lee Neubauer, Nicholas M. Dean, Kerry Blanchard, Jianyong Shou, Louis F. Stancato, Julia H. Carter, Eric G. Marcusson, Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity Journal of Clinical Investigation. ,vol. 117, pp. 2638- 2648 ,(2007) , 10.1172/JCI32044

Ke Dong, Rui Wang, Xi Wang, Fang Lin, Jian-Jun Shen, Ping Gao, Hui-Zhong Zhang, Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Research and Treatment. ,vol. 113, pp. 443- 456 ,(2009) , 10.1007/S10549-008-9956-X

Biljana Culjkovic, Keith Tan, Slobodanka Orolicki, Abdellatif Amri, Sylvain Meloche, Katherine L.B. Borden, The eIF4E RNA regulon promotes the Akt signaling pathway Journal of Cell Biology. ,vol. 181, pp. 51- 63 ,(2008) , 10.1083/JCB.200707018

Ivan Topisirovic, Biljana Culjkovic, Natalie Cohen, Jacqueline M Perez, Lucy Skrabanek, Katherine LB Borden, The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth. The EMBO Journal. ,vol. 22, pp. 689- 703 ,(2003) , 10.1093/EMBOJ/CDG069

A. Kentsis, I. Topisirovic, B. Culjkovic, L. Shao, K. L. B. Borden, Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 18105- 18110 ,(2004) , 10.1073/PNAS.0406927102

Natalie Cohen, Madhulika Sharma, Alex Kentsis, Jacqueline M Perez, Stephen Strudwick, Katherine LB Borden, PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA. The EMBO Journal. ,vol. 20, pp. 4547- 4559 ,(2001) , 10.1093/EMBOJ/20.16.4547

Katherine L B Borden, Ivan Topisirovic, Nadeem Siddiqui, Vincent Leroux Lapointe, Matthias Trost, Pierre Thibault, Catherine Bangeranye, Serafin Piñol-Roma, Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export‐competent RNP The EMBO Journal. ,vol. 28, pp. 1087- 1098 ,(2009) , 10.1038/EMBOJ.2009.53

Keith Tan, Biljana Culjkovic, Abdellatif Amri, Katherine L.B. Borden, Ribavirin targets eIF4E dependent Akt survival signaling Biochemical and Biophysical Research Communications. ,vol. 375, pp. 341- 345 ,(2008) , 10.1016/J.BBRC.2008.07.163